Catalyst Wire Dossier Catalyst Wire Dossier

Aggrenox ER

aspirin and dipyridamole · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aggrenox ER, covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers [Phase 1]

See pricing